Commit To Buy Jounce Therapeutics At $5, Earn 25.5% Annualized Using Options
December 30, 2019 at 11:55 AM EST
Investors eyeing a purchase of Jounce Therapeutics Inc (JNCE) stock, but cautious about paying the going market price of $8.32/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June 2020 put at the $5 strike, which has a bid at the time of this writing of 60 cents..